Yahoo Finance • 6 days ago
Renaissance Investment Management, an investment management company, released its Q2 2025 “Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The stock market was highly volatile in the second quarter.... Full story
Yahoo Finance • 6 days ago
As the United States stock market continues to reach new heights, with major indices like the S&P 500 and Nasdaq Composite posting consecutive weeks of gains, investors are paying close attention to high-growth sectors such as technology.... Full story
Yahoo Finance • 18 days ago
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals a... Full story
Yahoo Finance • 23 days ago
Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The "Immunoglobulin Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033" report has been added to R... Full story
Yahoo Finance • last month
As the U.S. market experiences slight gains, with the Dow Jones and S&P 500 inching higher amid anticipation for Nvidia's earnings report, investors are closely monitoring developments that could impact broader market sentiment. In such a... Full story
Yahoo Finance • last month
We came across a bullish thesis on ADMA Biologics, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.'s share was trading at $17.80 as of August 22nd. ADMA’s trail... Full story
Yahoo Finance • last month
President and CEO of ADMA Biologics NASDAQ:ADMA, Adam S. Grossman, sold 21,000 shares of common stock on August 15, 2025, for approximately $354,480. The shares were sold at a price of $16.88. The transaction comes as ADMA maintains strong... Full story
Yahoo Finance • last month
As the U.S. market experiences a mix of record highs and tempered expectations due to recent inflation reports, investors are closely monitoring economic indicators that could influence Federal Reserve policy decisions on interest rates. I... Full story
Yahoo Finance • 2 months ago
Investing.com - ADMA Biologics Inc (NASDAQ: ADMA) reported second quarter EPS of $0.1473, worse than the analyst estimate of $0.1533. Revenue for the quarter came in at $121.98M versus the consensus estimate of $124.13M. ADMA Biologics... Full story
Yahoo Finance • 2 months ago
2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted EBITDA(1) of $50.8 Million, a 59%... Full story
Yahoo Finance • 2 months ago
Major earnings expected after the bell on Wednesday include: * Realty Income Corporation (O [https://seekingalpha.com/symbol/O]) * Energy Transfer LP (ET [https://seekingalpha.com/symbol/ET]) * Occidental Petroleum Corporation (OXY... Full story
Yahoo Finance • 2 months ago
September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning as investors digested U.S. President Donald Trump’s latest tariff threats and weak economic data, while shifting t... Full story
Yahoo Finance • 2 months ago
RAMSEY, N.J. and BOCA RATON, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and... Full story
Yahoo Finance • 2 months ago
ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the 13 Best Low Risk High Growth Stocks to Buy. The company witnesses significant insider sales amid strong growth and strategic advances reported in the Q1 earnings report.Heavy Insider Sellin... Full story
Yahoo Finance • 3 months ago
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story
Yahoo Finance • 3 months ago
ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the Massive Sell-Offs: These 10 Stocks Shockingly Nosedived. ADMA Biologics fell by 14.7 percent week-on-week, closing Friday at $17.74 versus the $20.81 on June 13, as investors took path from... Full story
Yahoo Finance • 5 months ago
Futures rose as President Trump teased a "major trade deal" after indexes climbed as Trump eased AI curbs. MercadoLibre, AppLovin leapt late. Continue Reading View Comments... Full story
Yahoo Finance • 5 months ago
Stocks rose despite Fed stagflation fears as President Trump rescinded some AI chip curbs. MercadoLibre, AppLovin jumped late. Continue Reading View Comments... Full story
Yahoo Finance • 5 months ago
We recently published an article titled Why Traders Flocked to These 10 Stocks on Monday.In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against the other stocks. The stock market kicked off... Full story
Yahoo Finance • 5 months ago
We recently published a list of 10 Firms Mirror Wall Street Bloodbath. In this article, we are going to take a look at where ADMA Biologics Inc. (NASDAQ:ADMA) stands against other best worst-performing companies on Monday Wall Street kick... Full story